Source: FinanzNachrichten

Liminal BioSciences: Liminal BioSciences Inc.: LIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED ARRANGEMENT WITH STRUCTURED ALPHA LP

LAVAL, QC and CAMBRIDGE, England, Aug. 16, 2023 /PRNewswire/ -- Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), announced today that the Ontario Superior Court of...

Read full article »
Annual Revenue
$100K-5.0M
Employees
250-500
Kenneth Galbraith's photo - CEO of Liminal BioSciences

CEO

Kenneth Galbraith

CEO Approval Rating

90/100

Read more